Deferiprone, an iron chelator, alleviates platelet hyperactivity in patients with β-thalassaemia/HbE

Deferiprone, an iron chelator, alleviates platelet hyperactivity in patients with β-thalassaemia/HbE

Background: Hyperfunctional platelets play important roles in thromboembolism in patients with β-thalassaemia/ haemoglobin E (β-thal/HbE). Our previous study revealed ex vivo inhibitory effects of deferiprone on normal platelets. Herein, we aimed to investigate the in vivo effects on platelets in pa...

Cijeli opis

Bibliografski detalji
Glavni autori: Ngan Thi Tran, Pranee Sutcharitchan, Jindaporn Janprasit, Ponlapat Rojnuckarin, Noppawan Phumala Morales, Rataya Luechapudiporn
Format: Članak
Jezik:English
Izdano: BioExcel Publishing Ltd 2022-12-01
Serija:Drugs in Context
Teme:
arachidonic acid
deferiprone
iron overload
platelet aggregation
p-selectin
thalassaemia
Online pristup:https://www.drugsincontext.com/deferiprone-an-iron-chelator-alleviates-plateletbrhyperactivity-in-patients-with-%ce%b2-thalassaemia-hb-e/

Internet

https://www.drugsincontext.com/deferiprone-an-iron-chelator-alleviates-plateletbrhyperactivity-in-patients-with-%ce%b2-thalassaemia-hb-e/

Slični predmeti